Article
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jan 2017
Daly Mary B, Pilarski Robert, Berry Michael, Buys Saundra S, Farmer Meagan, Friedman Susan, Garber Judy E, Kauff Noah D, Khan Seema, Klein Catherine, Kohlmann Wendy, Kurian Allison, Litton Jennifer K, Madlensky Lisa, Merajver Sofia D, Offit Kenneth, Pal Tuya, Reiser Gwen, Shannon Kristen Mahoney, Swisher Elizabeth, Vinayak Shaveta, Voian Nicoleta C, Weitzel Jeffrey N, Wick Myra J, Wiesner Georgia L, Dwyer Mary, Darlow Susan
Abstract excerpt
The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer. The NCCN Genetic/Familial...
Topics
- Female
- Genetic Counseling
- Genetic Testing
- Hereditary Breast and Ovarian Cancer Syndrome
- Humans
- Mutation
- Practice Guidelines as Topic
- Risk Assessment
